Secondary Logo

Journal Logo

The neural mechanisms of mindfulness-based pain relief

a functional magnetic resonance imaging-based review and primer

Zeidan, Fadela,*; Baumgartner, Jennifer N.a; Coghill, Robert C.b

doi: 10.1097/PR9.0000000000000759
Special Issue on Innovations and Controversies in Brain Imaging of Pain-Methods and Interpretations
Open

The advent of neuroimaging methodologies, such as functional magnetic resonance imaging (fMRI), has significantly advanced our understanding of the neurophysiological processes supporting a wide spectrum of mind–body approaches to treat pain. A promising self-regulatory practice, mindfulness meditation, reliably alleviates experimentally induced and clinical pain. Yet, the neural mechanisms supporting mindfulness-based pain relief remain poorly characterized. The present review delineates evidence from a spectrum of fMRI studies showing that the neural mechanisms supporting mindfulness-induced pain attenuation differ across varying levels of meditative experience. After brief mindfulness-based mental training (ie, less than 10 hours of practice), mindfulness-based pain relief is associated with higher order (orbitofrontal cortex and rostral anterior cingulate cortex) regulation of low-level nociceptive neural targets (thalamus and primary somatosensory cortex), suggesting an engagement of unique, reappraisal mechanisms. By contrast, mindfulness-based pain relief after extensive training (greater than 1000 hours of practice) is associated with deactivation of prefrontal and greater activation of somatosensory cortical regions, demonstrating an ability to reduce appraisals of arising sensory events. We also describe recent findings showing that higher levels of dispositional mindfulness, in meditation-naïve individuals, are associated with lower pain and greater deactivation of the posterior cingulate cortex, a neural mechanism implicated in self-referential processes. A brief fMRI primer is presented describing appropriate steps and considerations to conduct studies combining mindfulness, pain, and fMRI. We postulate that the identification of the active analgesic neural substrates involved in mindfulness can be used to inform the development and optimization of behavioral therapies to specifically target pain, an important consideration for the ongoing opioid and chronic pain epidemic.

aDepartment of Anesthesiology, University of California San Diego, San Diego, CA, USA

bDepartment of Anesthesiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

Corresponding author. Address: Department of Anesthesiology, University of California San Diego, 9452 Gilman Dr, San Diego, CA 92093. Tel.: 858-246-2391; fax: 858-657-6559. E-mail address: fzeidan@ucsd.edu (F. Zeidan).

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Received January 05, 2019

Received in revised form April 24, 2019

Accepted April 25, 2019

Online date: July/August, 2019

This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Back to Top | Article Outline

1. Introduction

Mindfulness-based meditation practice is associated with promoting a wide-spectrum of health outcomes including anxiety, depression, and pain (see Ref. 22 for thorough review on mindfulness-based clinical interventions). The advent of modern neuroimaging and other objective methodological approaches has substantiated accounts from contemplatives and mindfulness practitioners supporting the purported health promoting benefits of mindfulness-based mental training. We postulate that the scientific field of mindfulness and other mind–body approaches has largely advanced because the health promoting benefits supporting mindfulness are not solely based on subjective reports, but rather, the discovery of the biological substrates supporting such improvements. The present review will delineate a brief, yet comprehensive review of the neural mechanisms supporting pain reductions from the perspective of interindividual variability in dispositional mindfulness, to brief, and long-term mindfulness-based mental training. We will also provide a brief primer to best conduct experiments combining pain-evoking procedures, mindfulness meditation, and functional magnetic resonance imaging (fMRI).

Back to Top | Article Outline

2. What is mindfulness?

Mindfulness is defined here as nonreactive awareness of the present moment experience. This construct can be developed and enhanced with mindfulness-based mental training. However, experience with mindfulness meditation is not a prerequisite to being mindful.24,32 There are a wide variety of mindfulness-based practices that are subsumed under the general rubric of mindfulness meditation.” Thus, it is critical that the operational specifics supporting mindfulness practices are fully described to promote cross-experimental methodological validity and reliability.32,72,103 In the context of the present review, the 2 primary forms of mindfulness practice are characterized as Shamatha (focused attention) and Vipassana (open monitoring).72,125

During focused attention practice, or Shamatha,125 the practitioner is taught to sustain attention on an automatic and dynamic stimulus, such as breath sensations, as an analogy for the qualitative aspects of the present moment. As attention drifts from the object of focus (eg, breath) to a distracting sensory event, the practitioner is taught to acknowledge the event without further reaction, to disengage from the discursive event, and then to return attention to the meditative object (eg, the breath). Shamatha training increases in complexity (eg, mindfulness of breath, emotions, and/or thoughts) as individuals develop expertise at each step. Shamatha practices aim primarily at gaining mental control and stabilization of attention, thus they naturally transition in a relatively undefined manner to open monitoring meditation, or Vipassana practice.

Vipassana meditation has been described as a state of nonappraisal and/or a nonelaborative mental stance.45,137 Indeed, there is little to no concrete consensus concerning where Shamatha ends and Vipassana begins. Vipassana practices are associated with an awareness of the awareness (ie, meta-awareness)37,99 of arising sensory, affective, or cognitive events. The Vipassana practitioner is said to experience each moment without evaluation or elaborative interpretation.

Traditionally, focused attention is taught before, or as a prerequisite to, open monitoring practice. The reason for this is likely that a greater capacity for attentional stability and mental control53,138 would allow more success in alleviating one's tendency to reflexively engage with, and appraise, ongoing experience. As the practitioner becomes more adept in meditation, he/she will be able to use a unique cognitive approach where consciously available sensory events can be simply “let go,” presumably leading to significant reductions in affective or cognitive appraisals/reactions to the event. Said another way, the practitioner “watches” experience as it unfolds over time without cognitive elaboration or emotional reactivity. As skills in mindfulness meditation continue to develop, the practitioner brings mindfulness more effortlessly into meditation and other aspects of everyday life.59 It is postulated that the state transitions to a trait as a function of practice frequency and neural plasticity. However, the cultivation of mindfulness does not exclusively require training in mindfulness meditation. Some individuals are simply more “mindful” than others, as evinced by higher scores on standardized measures of dispositional/trait mindfulness without any formal training in meditation.24,52,128,142

Back to Top | Article Outline

3. Why mindfulness for pain?

Given that pain is instantiated by a highly distributed network of brain mechanisms,21 treatments that work in a highly focal fashion on one neurotransmitter system or on one brain region or pathway are likely to be of limited efficacy. Treatments that can target multiple nodes within this distributed network are crucially needed. Mindfulness may have that ability because it uniquely enhances cognitive control,138 emotion regulation,73 acceptance (ie, nonreactivity),68,92,116 and improves mood.17,36 There is also a great deal of insight from Buddhist contemplatives in the way that mindfulness-based mental training impacts the subjective experience of pain. The Sallatha Sutta, a Theravadin Buddhist scripture from the Pali Canon (translated as The Arrow or The Dart), explicitly states that there is a key difference in how mindfulness trained and “untrained” individuals experience pain.3 The Sutta analogizes the reaction to pain to being stung by an arrow and, in the case of untrained individuals, being struck immediately after by a second arrow. The 2 arrows are described as representing physical and mental pain, respectively. The first arrow could refer to the noxious sensation one initially feels, while the second dart could be described as the worry, distress, and pain-evoked suffering that follows. The claim of Buddhist contemplatives is that mindfully trained individuals, because they do not cling to sensory pleasure, also do not engage cognitive and affective appraisals of pain.

Back to Top | Article Outline

4. Does mindfulness meditation relieve chronic pain?

Chronic pain affects more than 100 million Americans, 1.5 billion people worldwide, and costs the United States an estimated $635 billion per year in medical expenses and lost work productivity.33 Despite treatment advances, the pervasiveness and burden of chronic pain has dramatically increased Medicare expenditures for steroid injections (↑629%) and opioid treatments (↑423%).31 The widespread use of opioids to alleviate chronic pain has led to the so-called “opioid epidemic”84 with an exponential rise in opioid misuse and addiction.50,98 These staggering statistics signify the importance of developing fast-acting nonpharmacologic approaches to treat acute exacerbations of chronic pain. To this extent, the need for effective nonpharmacological treatment options has spurred much interest in mind–body approaches toward mitigating chronic pain. Mindfulness meditation-based interventions improve chronic pain symptomology across a wide range of pain conditions, including fibromyalgia,29,48 headache disorders,130 chronic pelvic pain,38 irritable bowel syndrome,41,44 and chronic lower back pain19,56,58,82,83—the most prevalent and financially burdensome chronic pain disorder. Research suggests that mindfulness meditation improves chronic pain symptomatology through unique mechanisms, such as disengagement from pain-related threat,119 extinction of fear conditioning, acceptance-based coping strategies,81 and strengthening one's ability to self-regulate affective appraisals of nociceptive input.42

Much of the work on the efficacy of mindfulness-based interventions for the treatment of chronic pain has focused on outcomes associated with mindfulness-based stress reduction (MBSR) and its varieties.56,57 Mindfulness-based stress reduction is a structuralized, group-based psychosocial intervention consisting of mindfulness meditation, yoga, and cognitive-behavioral therapy with the goal of integrating mindfulness into everyday life. In their seminal work, Kabat-Zinn et al.56 showed that a 10-week MBSR program reduced pain reports, pain-related behaviors and improved general vitality in chronic pain patients, effects that were maintained at 15-month follow-up.58 However, this initial work lacked a control group, and thus, while promising, subsequent research was warranted. A more recent study showed that MBSR produced greater reductions in pain catastrophizing in chronic low-back pain patients compared with cognitive-behavioral therapy (CBT) and standard of care.118 It is interesting that MBSR outperformed CBT given the explicit focus of CBT on controlling maladaptive thoughts and behaviors, suggesting that mindfulness training may uniquely buffer against future-oriented, catastrophic thinking. In fact, growing research suggests that the nonreactivity component of mindfulness is negatively related to pain catastrophizing.30 However, the long-term benefits of MBSR on pain catastrophizing are questionable because group differences were no longer significant at follow-up,118 implying that training should to be continued to facilitate lasting changes in the propensity to catastrophize. By contrast, in a seminal study, Cherkin et al.19 found that both MBSR and CBT significantly improved ratings of functional limitations, pain-related distress, and pain intensity in chronic lower back pain patients when compared with standard of care. In the same study, findings persisted for MBSR and CBT at 8-, 26-, and 52-week follow-up, demonstrating the durability of mindfulness on certain pain-related outcomes over time. Taken together, this growing body of work demonstrates that a few weeks of mindfulness training improves pain and health outcomes in people suffering from chronic pain, and with some evidence of persistent benefit. Yet, the precise neural mechanisms supporting pain relief by mindfulness meditation remains relatively uncharacterized.

Back to Top | Article Outline

5. Multiple neural mechanisms supporting mindfulness-based pain reductions

Electrophysiological (EEG) and brain imaging methods have provided an important avenue for elucidating the neural mechanisms supporting the modulation of pain by mindfulness meditation. Converging lines of evidence demonstrate that mindfulness-based analgesia engages distinct neural processes that vary across training level. Here, we will delineate the neural mechanisms supporting mindfulness-based pain modulation across no to brief to long-term training levels. We will focus primarily on studies using fMRI.

Back to Top | Article Outline

5.1. Brain mechanisms supporting the relationship between higher trait mindfulness and lower pain sensitivity

Individuals that have never practiced mindfulness meditation may still be highly mindful as a function of genetics, environment, psychosocial, and cultural factors. Trait or dispositional mindfulness is the innate propensity to be aware of the present moment in a nonreactive manner.27 Trait mindfulness can also be developed and increased through mindfulness-based mental training. Individuals who are low on the trait mindfulness spectrum exhibit higher pain in a number of clinical pain populations.81,90,100 Two recent studies combined psychophysics, noxious heat stimulation, and distinct functional neuroimaging techniques to identify the neural mechanisms supporting the postulated relationship between trait mindfulness and pain sensitivity142 and pain threshold.52 Zeidan et al.142 used perfusion-based arterial spin labeling (ASL) fMRI to determine the significant relationship between higher dispositional mindfulness (as measured by the Freiburg Mindfulness Inventory) and lower pain ratings in response to noxious heat (49°C).142 As hypothesized, higher trait mindfulness was associated with greater deactivation of the posterior, midline nodes of the so-called default mode network. The default mode network is defined by oscillating activity within a group of distinct brain regions (medial prefrontal cortex, posterior cingulate cortex [PCC]/precuneus, inferior, and lateral temporal cortices) and is associated with facilitating self-referential processes.28,76,91,107 Specifically, greater deactivation of the dorsal PCC and precuneus was associated with higher trait mindfulness, and greater activation of the dorsal PCC during noxious heat was associated with higher pain reports during noxious heat (Fig. 1).142 In a similar study employing functional connectivity analyses with blood oxygen level-dependent (BOLD) signaling fMRI, Harrison et al.52 found that greater trait mindfulness (measured by the Five Facet Mindfulness Questionnaire) was associated with higher pain threshold values. Higher trait mindfulness was associated with weaker connectivity between the central nodes of the default mode network (ie, medial prefrontal cortex, PCC/precuneus) and stronger connectivity between the precuneus and somatosensory cortices. These findings are remarkably consistent with the principles of mindfulness supporting the disposition to attend to immediate sensory aspects of experience and the ability to disengage from immediate appraisals and corresponding ruminations. Taken together, these 2 studies provide unique mechanistic insight that trait mindfulness is associated with lower pain and lower PCC/precuneus processing, suggesting that trait mindfulness is associated with a lower propensity to ruminate on65 and personalize4 the appraisal of arising noxious sensory events.142 Furthermore, individuals who exhibit higher trait mindfulness may have a greater ability to decouple noxious sensory discriminations from affective appraisals.142 This is important because even brief bouts of mindfulness training (less than a week) can significantly increase dispositional mindfulness on average by 13%.135,138,139,141 These findings could assist us to better develop and tailor adjunctive pain therapies to specifically target reductions in PCC/precuneus and increase trait mindfulness activity to treat pain.

Figure 1

Figure 1

Back to Top | Article Outline

5.2. Neural and physiological processes supporting mindfulness-based pain relief after brief mental training

Longitudinal and carefully controlled studies examining the effects of brief mental training regimens can provide insight into measuring explicit changes in behavioral and physiological pain responses. To this extent, it is now well established that mindfulness meditation significantly reduces pain after brief mental training (4 days > 4 weeks).62,134–136,141 In one of the first preliminary studies to examine the effects of mindfulness meditation on pain, Kingston et al.62 found that 6 hours of mindfulness-based mental training was associated with higher pain tolerance during the cold pressor test, when compared with an active, visual imagery-based (“imagine walking through a garden”) control condition. The authors reported no significant between-group differences in mindfulness (as measured by the Kentucky Inventory of Mindfulness Skills), blood pressure, or mood.62

Others have postulated that mindfulness-induced pain relief engages mechanisms supporting divided attention, relaxation, and/or positive mood.15,55 To better address this issue, Zeidan et al.,138 across 3 separate experiments, dissected the pain relieving effects of mindfulness meditation regimen (three 20-minute Shamatha + Vipassana training sessions) from a robust, math distraction and relaxation condition during noxious electrical stimulation. Mindfulness meditation during noxious electrical stimulation significantly reduced pain responses above and beyond analgesia observed during math distraction and relaxation. Surprisingly, mindfulness meditation training significantly increased pain threshold when compared with before the intervention and the control group.138 These findings provided credence that mindfulness-based pain relief may engage unique physiological mechanisms from other cognitive techniques to reduce pain.

In their follow-up study, Zeidan et al.141 examined the behavioral and neural mechanisms supporting state mindfulness-induced pain relief before and after a brief, mindfulness training regimen (four 20-minute sessions) during noxious heat (49°C) in healthy participants. In the pre- and post-fMRI sessions, participants were instructed to “begin meditating and to focus on the changing sensations of the breath” during noxious heat- and perfusion-based fMRI (ASL). Focusing on the breath before the intervention reduced pain unpleasantness ratings but not pain intensity ratings when compared with rest. After training, mindful attention to the breath significantly reduced pain intensity (↓40%) and pain unpleasantness (↓57%) ratings when compared with rest. Mindfulness meditation produced widespread activation of the (1) ACC extending from the dACC to the perigenual ACC (pgACC), (2) bilateral orbitofrontal cortex (OFC), (3) the primary somatosensory cortices (SI) corresponding to the face region, (4) bilateral ventral striatum, and (5) deactivation of the default mode network.141 In the presence of noxious heat, mindfulness significantly reduced SI activation corresponding to the stimulation site (right leg), suggesting that mindfulness reduces ascending nociceptive inputs to somatosensory cortical regions. Regression analyses revealed that greater pain relief was directly associated with greater activation of the pgACC, right anterior insula, and bilateral OFC. Greater mindfulness-based pain relief was also associated with significant extensive, bilateral deactivation of the thalamus, a critical node of ascending nociceptive information from the spinal cord (Fig. 1).49 These findings are particularly consistent with the principles of mindfulness. That is, the pgACC facilitates top-down regulation of negative effect, affective modulation of pain, and autonomic regulation.11,16,101,120,121 The right anterior insula has been repeatedly implicated in processing interoceptive awareness and regulation of nociception.20,21,26,64,86,109,111 The OFC, a highly evolved brain region, is associated with increasing positive mood and altering the contextualization of arising sensory events.35,85,88,94 We propose a working theoretical framework that connects mindfulness-based pain relief with multiple, neural mechanisms that support both cortico-cortical and cortico-thalamo-cortical interactions.

Randomized, placebo-controlled studies are characterized as the “gold standard” to defining the effectiveness and active novel pain relieving treatments. Yet, placebo-controlled meditation studies have been very limited. This is problematic when considering that meditation is very susceptible to placebo responses and nonspecific effects such as slow breathing, demand characteristics, beliefs related to practicing meditation, conditioning, posture, among others. Thus, in the follow-up experiment, Zeidan et al.135 examined if the physiological and neural (ASL fMRI) mechanisms supporting mindfulness-based pain relief are distinct from those engaged by different placebo conditions. Healthy, pain-free participants were randomly assigned to 1 of 4 (four 20-minute/session) training regimens: (1) a mindfulness meditation akin to one previously described, (2) a placebo cream conditioning, (3) a sham mindfulness meditation, and 4) a book-listening control. Participants in the placebo-conditioning group were led to believe that the effects of an experimental form of Lidocaine was being evaluated, in which the pain-relieving effects of the cream (petroleum jelly) progressively increased with repeated application. Participants were led to believe that the cream was analgesic by covertly reducing stimulus temperature after application of the cream in each conditioning session. The sham mindfulness regimen mirrored mindfulness meditation on all nonspecific and psychosocial factors (posture, breathing, and eyes closed), but without the explicit training on focusing on the changing sensations of the breath in a nonreactive fashion. Thus, this group (theoretically) allowed us to disentangle the active mechanisms that were specific to mindfulness. All conditions significantly reduced pain intensity and pain unpleasantness ratings compared to the book-listening controls. Mindfulness meditation was more effective than placebo cream, placebo (sham) mindfulness, and control conditions at reducing pain ratings. The neural mechanisms supporting mindfulness-based pain relief were, again, found to be associated with greater activation in the OFC, pgACC, and right anterior insula.135 There was also significant deactivation of the PAG and thalamus, replicating and extending on the findings described in the previous ASL study.141 Placebo cream-induced pain relief was associated with significant reductions of contralateral, nociceptive somatosensory areas (ie, parietal operculum and secondary somatosensory cortices [SII]) and greater activation of the dorsolateral prefrontal cortex [DLPFC]), likely reflective of perceive controllability of pain5,97,102 and lower expectations for pain.6,64 This was the first ASL fMRI placebo experiment and largely replicated the findings supporting other pain-placebo–focused brain imaging studies.11,14,63,64,70,122,123 Regression analyses revealed that sham mindfulness induced pain relief was associated with lower respiration rate. These findings provide clear mechanistic distinctions between mindfulness and placebo. As described earlier, mindfulness engages multiple mechanisms supporting top-down regulation of pain. By contrast, sham mindfulness meditation likely employs bottom-up processes. Taken together, these findings provide robust evidence that the state effect of mindfulness meditation, after brief mental training, significantly reduces pain and recruits multiple, distinct neural processes from robust placebo conditions.

Back to Top | Article Outline

6. Neural mechanisms supporting pain relief after extensive mindfulness meditation experience

Research employing individuals with extensive mindfulness meditation experience (>1000 hours of practice) has provided insight into the ability of adept practitioners to evoke more stabilized, state- and trait-level changes in nociceptive processing, and corresponding pain responses. There is reliable and growing evidence demonstrating that long-term mindfulness practice can lead to significant increases in pain threshold values and lower pain sensitivity even when participants are not explicitly practicing mindfulness.13,19,43,46,82,83 Grant and Rainville46 were the first to demonstrate that adept Zen practitioners (a mindfulness practice similar to Vipassana) required significantly higher noxious heat stimulation to report the same level of pain as age-matched controls. In a follow-up fMRI (BOLD) study using a functional connectivity analyses during noxious heat stimulation and overlapping participant sample, Zen practitioners exhibited a significant decoupling between brain regions supporting nociceptive processing (thalamus; insula; SII) and sensory/affective appraisal (dlPFC; dACC) when compared with age-matched controls (Fig. 1).45 Greater decoupling between these brain regions was associated with higher pain tolerance in the Zen group. The authors postulated that the Zen practitioners preserved the capacity to attend to sensations but reduced affective appraisals of said sensory events. Importantly, practitioners were not meditating in this study, potentially providing credence of longstanding Buddhist accounts implicating extensive mindful practice with pronounced, trait-like changes in subjective experience and perception. Another study examined the state effects of mindfulness on pain responses and corresponding brain mechanisms (BOLD fMRI) in long-term Vipassana practitioners and demographically matched meditation naïve controls.40 Practicing mindfulness in response to 1-second noxious electric stimuli reduced pain unpleasantness (↓22%) and anticipatory anxiety (↓29%) ratings when compared with rest and control conditions. Surprisingly, mindfulness meditation did not significantly reduce pain intensity ratings when compared with controls. Mindfulness-based pain relief was associated with decreased activation in the lateral PFC and increased activation in the right posterior insula/SII.40 The authors postulated that this reflects “decreased cognitive control.” One could also take the perspective132,137,143 that mindfulness was associated with enhanced cognitive flexibility, potentially reflected by observed increases in rACC during meditation. Other groups45,114 have also postulated that it requires a significant degree of cognitive-affective control to reduce appraisals (↓PFC) of ascending noxious sensory events.

To this extent, one of the defining features of mindfulness meditation is the emphasis on nonevaluative awareness of present moment experience. It can reasonably be construed, then, that this experiential acceptance should reduce expectations of impending noxious stimuli that could exacerbate the pain experience.64,140 Lutz et al.71 tested this postulation by examining the influence of long-term mindfulness meditation (>10,000 hours of practice in the Nyingma and Kagyu traditions of Tibetan Buddhism) on psychophysical and neural responses to noxious heat stimulation. Control participants were nonmeditators that were instructed to practice mindfulness at home for 1 week. Surprisingly, both adept and novice meditators reduced pain intensity ratings during Shamatha practice and noxious heat, and there were no significant group differences. Vipassana-based meditation produced significant pain unpleasantness reductions in the adept meditators when compared with novices. The adept meditators exhibited less activation in the contralateral anterior insula and the rostral aspect of the midcingulate cortex during the prestimulus period when compared with controls. Furthermore, the greater the meditative experience, the greater the deactivation of said regions. Brown and Jones13 used electroencephalography (EEG) and pain-evoking laser stimulation to examine behavioral and EEG pain responses in adept meditators. Similar to Lutz et al., they found that lower pain responses were associated with significantly lower anticipatory event-related potentials in the inferior parietal and midcingulate cortex in the meditation but not control group.13 Greater meditative experience also predicted lower anticipatory EEG responses and greater pain relief. Remarkably, these effects were detected during a nonmeditative state and provided a clear scope of the trait-like pain modulatory changes that can occur with extensive mindfulness training.13 Finally, in a recent preliminary study, Taylor et al.115 recruited 11 adept meditators (>1000 hours of training in the Zen, Bodhicitta, and Kadampa tradition) and 51 control subjects to examine whether mindfulness reduces pain and anticipatory skin conductance reactions, specifically the nociceptive flexion reflex, in response to a fear condition task and noxious electrical stimulation. They found that the meditation group exhibited less pain sensitivity and reduced fear-induced pain facilitation than controls. Meditators and nonmeditators displayed comparable nociceptive flexion reflexes, suggesting that mindfulness does not (1) modulate nociceptive processes at the level of the spinal cord, (2) engage classical descending inhibition of pain mechanisms, and (3) reduce anticipatory responses corresponding to conditioned pain-focused fear response, but rather direct expectations of impending stimuli, a finding consistent with previous work.13,71 The authors further speculated that reductions in fear-conditioned pain learning might be a mechanism by which mindfulness reduces the progression of acute to chronic pain. Taken together, these mechanistic findings13,71,115 show that attenuating the expectations of impending sensory events by sustaining attention in the present moment are directly associated with facilitating mindfulness-based pain relief.

Back to Top | Article Outline

7. The role of endogenous opioidergic systems (or lack thereof) in mindfulness-induced pain relief

A plethora of endogenous neurotransmitters, including the cannabinoid, serotonergic, dopaminergic, and opioidergic systems, at least, are partially engaged in the cognitive modulation of pain.7,127 To date, the endogenous opioidergic system is characterized as the primary endogenous pain modulatory system.127 Higher order brain regions (PFC; rACC) project to the PAG, the rostral ventral medulla, and the dorsal horn of the spinal cord to reduce the elaboration of spinal and supraspinal nociceptive processing through the release of endogenous opioids9,77,78 that largely bind with mu, delta, and kappa receptors.54,69 Pain relief produced by placebo,2,34,47,67,147 acupuncture,51 conditioned pain modulation,61 distraction,108 and hypnosis39,110 is meditated, in part, by endogenous opioidergic systems.

Mindfulness-based analgesia, after brief mental training, is associated with greater activation of the rACC, OFC, and insular cortices, brain regions that contain high concentrations of opioid receptors.18,117,124 However, mindfulness meditation also deactivates the PAG, a central node in opioidergically mediated descending inhibition of pain.7 To bridge this exploratory gap, Zeidan et al.134 conducted a double-blinded, randomized study of healthy, meditation-naïve participants to determine whether mindfulness pain relief engages endogenous opioids in response to intravenous administration (IV) of placebo saline and high-dose naloxone, the opioid antagonist, when compared with a book-listening control. In brief, mindfulness, after brief mental training, effectively reduced behavioral responses in the presence of opioid blockade and saline, demonstrating that mindfulness-based analgesia is not mediated by endogenous opioids. As a supplementary query, one could postulate that mindfulness-based pain relief, after extensive mindfulness training, could engage endogenous opioidergic systems due to progressive development of opioidergically driven processes such as conditioning, expectations, and other placebo-type mechanisms. Using a double-blinded, cross-sectional design, May et al. (2018) assessed the role of endogenous opioids in mindfulness-based pain relief in adept mindfulness practitioners with extensive training (>4,000 hours of practice). Surprisingly, when compared with saline and the control group, high-dose IV naloxone infusion produced greater pain relief in the meditation group, providing further evidence that mindfulness across training levels produces analgesia independent of endogenous opioids.79 We postulated that expert meditators may have exerted more effort in the presence of naloxone to counteract the effect of naloxone, and that other nonopioidergic systems10 may have been engaged to compensate for opioid blockade.89 By contrast, another group used a randomized, crossover design and reported that mindfulness-based pain relief was reversed by naloxone105 in response to a brief (10 seconds) noxious cold stimulus. In our rebutting commentary of this study, we postulated that the authors' interpretations were not justified because of the significant decrease in pain (ie, ↓19%) during mindfulness and naloxone infusion and the comparable reductions during meditation and saline infusion (ie, ↓25%).133 Importantly, the authors did not directly statistically compare the differences in pain between the saline and naloxone conditions, which begs the question on why they used the elegant crossover-controlled design. The authors go on to say in their rebuttal to our commentary104 that “experience seems to be a crucial factor in opioid involvement in mindfulness meditation.” Our recent study demonstrating that mindfulness-based analgesia is more pronounced during naloxone in long-term meditators (mean experience >4000 hours of meditation practice) potentially invalidates this interpretation.79 Taken together, these findings are important because they provide supplementary evidence that mindfulness engages unique mechanisms to reduce pain that are distinct from those mediated by placebo analgesia (ie, endogenous opioids; ↓ PAG). Because opioid and nonopioid processes synergistically interact with reduce pain, these findings suggest that mindfulness could be used in conjunction with traditional pain therapies to optimize analgesia, an important finding for the millions of chronic pain patients seeking effective, self-regulatory pain therapy.

Back to Top | Article Outline

8. A brief primer: functional neuroimaging of mindfulness and pain

The widespread employment of functional neuroimaging methodologies and identification of the health promoting mechanisms supporting meditation is credited with the explosive proliferation of mindfulness-based research. Functional magnetic resonance imaging, positron emission tomography (PET), and ASL fMRI have provided means to collect direct (perfusion-based fMRI; PET) and indirect (BOLD; fMRI) measures of cerebral blood flow (CBF), which provide higher spatial resolution (ie, indicating where neural activity may be occurring), although this comes at a tradeoff, with poorer temporal resolution (2–5 seconds) than EEG/event-related potential. Here, we will provide very brief suggestions on how to best conduct mindfulness-pain research in combination with fMRI.

Back to Top | Article Outline

8.1. Arterial spin labeling or blood oxygen level–dependent functional magnetic resonance imaging to study state mindfulness and pain?

Both ASL and BOLD fMRI examine CBF to make inferences about neural activity. There are a number of reasons that we propose that perfusion-based, ASL fMRI method is more appropriate for examining the effects of state mindfulness meditation when compared with BOLD fMRI. Arterial spin labeling fMRI provides a fully quantifiable and direct measurement of CBF (mL/100 g of tissue/min). By contrast, BOLD is an indirect surrogate of CBF that assesses blood oxygen in arbitrary units. When compared with BOLD fMRI, ASL is less sensitive to low-frequency drifts in signal intensity that can occur as an individual's body relaxes as a function of time or as the scanner heats up over the course of an imaging series.126 Accordingly, BOLD fMRI is not well suited to appropriately image task-related brain activation longer than 30 seconds.1 Furthermore, when compared with BOLD, ASL fMRI can reliably assess rostral neural regions, such as the OFC,126 a brain area repeatedly implicated in mindfulness meditation,135,141 but suffering from substantial susceptibility artifacts. Nevertheless, BOLD fMRI does enjoy higher signal-to-noise ratio when compared with ASL.87 Thus, the utility of ASL vs BOLD comes down to the primary aims of the study.

Back to Top | Article Outline

8.2. State mindfulness produces respiration-induced functional magnetic resonance imaging artifacts

As fMRI scanners increase their respective field strengths, physiological noise has become a significant confound reducing the applicability and generalization of functional neuroimaging findings.93 This is an important caveat because state mindfulness meditation reliably (1) reduces respiration rate and, in parallel, decreases CBF due to lower arterial levels of carbon dioxide60,131 and (2) alters chest movements that cause magnetic field changes, rendering a physiological artifact.112 This is problematic because meditation-induced changes in breathing are directly task-specific and can dramatically misconstrue the interpretation of findings. The changes in breathing are meditation-specific, and the brain (de) activations could be interpreted as meditation-related mechanisms, when they are potentially due to physiological noise.12,96 In our laboratory, we have seen (unpublished findings) significantly greater white-matter activation when compared with gray matter during meditation practice. One can make the mistake of regressing out each individual's respiration rate from his or her respective fMRI analysis. However, that would likely remove neuronal activation that directly corresponds to mindfulness-based breath focus, as opposed to controlling for physiological noise. Furthermore, the employment of perfusion fMRI may not directly correct for physiological artifacts, although it is better suited to identify if CBF deviations occurred (ie, ASL produces fully quantifiable CBF measurements). Thus, it is critical that researchers evaluate and correct for this issue by (1) collecting respiration data, (2) visually inspecting data for significantly greater white-matter activation when compared with gray matter, (3) segmenting and comparing white-matter and gray-matter brain, and (4) inputting segmented white values as covariates of no interest in the statistical analyses using a component-based noise correction method (CompCor; temporal or anatomical variants).8

Back to Top | Article Outline

8.3. ON/OFF block functional magnetic resonance imaging designs are not appropriate to examine state mindfulness

Functional neuroimaging experiments use “ON/OFF” block designs to identify brain activation corresponding to any specific event (eg, noxious stimulation; cues; appraisals corresponding to a stimulus, etc.). For example, a traditional BOLD-based fMRI experimental paradigm may be designed to contrast brain activation in response to 10-second plateaus of noxious, 49°C and innocuous 35°C heat, respectively. The 49° stimulus is generally characterized as the “on” and 35°C as the “off” condition, respectively. Because this hypothetical experimental paradigm controls for contact of the thermal probe and change in stimulus temperature, significant brain activation could be interpreted as brain activity corresponding to 49°C when compared with 35°C, and vice versa. However, this on–off paradigm cannot be used to measure state mindfulness. That is, directing subjects to meditate for 10 seconds (ON) and rest (OFF) for 10 seconds will lead to contamination of the “OFF” period because the cognitive state of mindfulness meditation cannot be “turned off and on” like a thermal stimulus. There are carryover effects from mindfulness meditation that can last minutes to days. Thus, we propose starting the experiment with rest (ie, nonmeditation) for the first half of the experiment and instructing subjects to meditate in the second half of the study. This paradigm is weakened by obvious order effects, but using a paralleling nonmanipulation group/condition can easily control this for experimental confound. It is important to note that these recommendations are explicit to state mindfulness meditation activation studies. It is perfectly acceptable to use BOLD fMRI-based resting state functional connectivity analyses to measure stabilized changes in neural functioning because ASL fMRI is not yet optimized for connectivity studies.

Back to Top | Article Outline

8.4. Strong control conditions are critical to disentangle mechanisms supporting mindfulness-based analgesia

The neural mechanisms supporting mindfulness-based practices still remain poorly characterized.113 Mindfulness-based pain relief is believed to be associated with a spectrum of nonspecific factors such as distraction, slow breathing, placebo, conditioning, facilitator attention, social support, body posture, relaxation, and demand characteristics. This is a limitation in fostering the validity of this practice to relieve pain. We suggest that mindfulness-pain neuroimaging studies should use comparison conditions that most closely resemble mindfulness practices and suited to disentangle the mechanisms that are postulated to be engaged by mindfulness. To better address this issue, we recently developed and validated a sham-mindfulness meditation comparison condition.135,139 Sham-mindfulness meditation (ie, placebo mindfulness) was designed, so that the primary difference between the mindfulness and sham-mindfulness practice was the explicit instructions corresponding to the nonreactive attention to the breath sensations used in the mindfulness meditation. Participants were first instructed that they were randomly assigned to the mindfulness meditation group, and that mindfulness training was secular. In each of the training sessions, subjects were instructed to close their eyes, and to take a deep breath “as we sit here in meditation” every 2 to 3 minutes.135,139 All other aspects of the sham-mindfulness meditation intervention (ie, posture, training room, facilitator; time spent providing instructions; and eyes closed) matched the mindfulness meditation-training regimen. We also paralleled the fMRI-session's experimental directives (“begin practicing mindfulness meditation until the end of the experiment”) across the mindfulness and sham-mindfulness groups.

Other appropriate fMRI controls for mindfulness include divided attention tasks,55,106,136 relaxation conditions,136 cognitive-behavioral therapies, and techniques that may share mechanisms that may be engaged by mindfulness (ie, slow breathing manipulations). Some recent studies have successfully disentangled the active mechanisms supporting mindfulness-based health promotion. Creswell et al.23 compared behavioral, inflammatory stress [ie, interleukin-6 (IL-6)] and neural mechanisms supporting an intensive 3-day mindfulness meditation and 3-day health enhancement relaxation program in unemployed and clinically stressed adults. All aspects of the relaxation program were matched to the mindfulness regimen intervention (including time of the interventions held on the same weekends and even the location of the intervention). Mindfulness-induced stress reductions were associated with stronger functional connectivity between the PCC and dlPFC, mechanisms supporting executive-level control of emotions. By contrast, the relaxation group exhibited higher IL-6 responses after the intervention. Another group used a health enhancement program (HEP) to disentangle the mechanisms supporting mindfulness.74,75,95 The HEP controlled for facilitator allegiance, social support, and other components related to participating in a mindfulness program. Although the HEP and mindfulness conditions were effective at improving mood, stress, and cognition, they did not significantly differ. However, the mindfulness program was more effective at reducing inflammatory markers in response to a social stress test95 and pain.74 Taken together, these findings demonstrate that some mindfulness techniques are not more beneficial than active controls on some health outcomes (stress and cognition) but superior on other outcomes (pain). Nevertheless, they demonstrate that mindfulness engages unique health-promoting mechanisms that are important to better optimize the development and tailoring of said interventions for different patient populations.

Back to Top | Article Outline

8.5. Mindfulness training for the scanner

In light of the ongoing opioid epidemic, nonpharmacological pain therapies such as mindfulness-based approaches will continue to be examined by combining subjective reports and functional neuroimaging methodologies. We have provided a number of supplementary suggestions that may aid in conducting mindfulness-pain fMRI studies. Practicing mindfulness meditation is quite difficult to perform in a quiet room. Mindfulness practice difficulty is exacerbated in the fMRI environment. The scanner (1) is very loud, (2) confines the individual, and (3) renders the participant unable to practice mindfulness in an upright, seated position. To address this, we and others66 have conducted mindfulness training while subjects are lying down and during an audio recording of the scanner sounds. We initially begin our mindfulness training regimens while subjects are in a more traditional pose (ie, sitting up in a chair) and then instruct individuals to lie in the supine to practice with the sounds of the scanner (after the first, 3 training sessions). We also recommend conducting mindfulness training in a “mock scanner” or a similar environment to better control for claustrophobic individuals and to better prepare subjects to meditate in the scanner.

Back to Top | Article Outline

9. Considerations and future steps for mindfulness-based pain research

Here, we show that mindfulness meditation-based pain relief does not engage one particular brain mechanism to reduce pain, but rather a combination of processes that are reflective of effortful, reappraisal processes. In light of Francis Crick's “speculative…searchlight hypothesis,”25,80 we propose that the observed relationship between mindfulness-based pain relief and thalamic deactivation reflects a remote tuning mechanism that is facilitated by feedback connections between excitatory, glutamatergic OFC innervations on the thalamus and subsequently the inhibitory, GABAergic thalamic reticular nuclei (TRN).144–146 Coincidently, these neuroanatomical projections (OFC > TRN) reflect a gating mechanism of ascending sensory information that selectively modulates, through higher order cognitive control processes (ie, focusing on breath sensations), sensory and emotional salience of said sensory events to significantly reduce the thalamic transmission to early somatosensory cortices (ie, SI). This mechanism is critically involved in integrating real-time sensory and affective information,129 assessing value,49 and regulating “passage to the cortex”.146 Unfortunately, ASL fMRI does not provide optimized means to directly test this hypothesis using functional connectivity analyses, due to low signal-to-noise resolution. Nevertheless, these findings demonstrate that mindfulness-based pain relief engages multiple brain mechanisms that are relatively distinct from other cognitive manipulations. Importantly, the Zeidan et al. (2011) study lacked a matched and active control group, and thus, it was difficult to explicitly ascertain whether mindfulness reduces pain through brain mechanisms that are reflective of placebo analgesia.

The postulated mechanisms supporting mindfulness-based pain relief may not explicitly relate to eradicating the intensity of pain but suggest that mindfulness alters the contextual evaluation of innocuous and noxious sensory events. Mindfulness meditation, across all reported pain focused studies, impacted the affective dimension of pain more so than sensory pain. However, more brain imaging research is needed to clearly extrapolate the mechanisms that mindfulness impacts chronic pain, as the large proportion of said fMRI-mindfulness studies were conducted in healthy individuals. To this extent, it will no doubt be fruitful to incorporate PET studies to better identify neurochemical-based interactions supporting mindfulness-based analgesia. This line of research would, if properly designed, provide a clear understanding of the different classes of neurotransmitters involved in mindfulness and provide another means of testing our working hypothesis on the role of the TRN in modulating pain. Mindfulness is susceptible to nonspecific effects, thus we highly recommend appropriate placebo-based comparisons to better isolate genuine mindfulness mechanisms. We also need to better characterize the neural mechanisms supporting mindfulness-based pain relief in specific chronic pain populations. For instance, the neural processes supporting pain relief in chronic low-back pain may differ from those found to be effective at treating migraine pain. We also need to appreciate how long the effects of meditation last and how much training is required. Nevertheless, it is clear that mindfulness effectively reduces pain and does so by engaging processes that reflect changes in one's relationship with respective pain. This is important for those seeking ways to reduce the impact of developing chronic pain and the common comorbidities (anxiety and depression) that exacerbate the pain experience. We predict that the mechanisms supporting mindfulness-based pain relief become more robust with more practice, a distinction from traditional pain therapies that exhibit increasing tolerance and plateaus in efficacy. When considering the ongoing chronic pain and opioid epidemic, the utility of mindfulness meditation may prove to be an important tool to teach individuals to self-regulate pain directly with a present-centered and acceptance-based strategy.

Back to Top | Article Outline

Disclosures

The authors have no conflict of interest to declare.

Back to Top | Article Outline

References

[1]. Aguirre GK, Detre JA, Zarahn E, Alsop DC. Experimental design and the relative sensitivity of BOLD and perfusion fMRI. NeuroImage 2002;15:488–500.
[2]. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 1999;19:484–94.
[3]. Andersen D, Smith H. The sutta-nipta. London: published for the Pali Text Society by Luzac, 1965.
[4]. Andrews-Hanna JR, Reidler JS, Sepulcre J, Poulin R, Buckner RL. Functional-anatomic fractionation of the brain's default network. Neuron 2010;65:550–62.
[5]. Atlas LY, Bolger N, Lindquist MA, Wager TD. Brain mediators of predictive cue effects on perceived pain. J Neurosci 2010;30:12964–77.
[6]. Atlas LY, Wager TD. How expectations shape pain. Neurosci Lett 2012;520:140–8.
[7]. Basbaum AI, Fields HL. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 1984;7:309–38.
[8]. Behzadi Y, Restom K, Liau J, Liu TT. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage 2007;37:90–101.
[9]. Beitz AJ. The organization of afferent projections to the midbrain periaqueductal gray of the rat. Neuroscience 1982;7:133–59.
[10]. Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 2011;17:1228–30.
[11]. Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. PAIN 2006;120:8–15.
[12]. Birn RM, Murphy K, Handwerker DA, Bandettini PA. fMRI in the presence of task-correlated breathing variations. NeuroImage 2009;47:1092–104.
[13]. Brown CA, Jones AK. Meditation experience predicts less negative appraisal of pain: electrophysiological evidence for the involvement of anticipatory neural responses. PAIN 2010;150:428–38.
[14]. Buchel C, Geuter S, Sprenger C, Eippert F. Placebo analgesia: a predictive coding perspective. Neuron 2014;81:1223–39.
[15]. Buhle J, Wager TD. Does meditation training lead to enduring changes in the anticipation and experience of pain? PAIN 2010;150:382–83.
[16]. Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption in chronic pain. Nat Rev Neurosci 2013;14:502–11.
[17]. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosomatic Med 2003;65:571–81.
[18]. Casey KL, Svensson P, Morrow TJ, Raz J, Jone C, Minoshima S. Selective opiate modulation of nociceptive processing in the human brain. J Neurophysiol 2000;84:525–33.
[19]. Cherkin DC, Sherman KJ, Balderson BH, Cook AJ, Anderson ML, Hawkes RJ, Hansen KE, Turner JA. Effect of mindfulness-based stress reduction vs cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: a randomized clinical trial. JAMA 2016;315:1240–9.
[20]. Coghill RC, Sang CN, Maisog JM, Iadarola MJ. Pain intensity processing within the human brain: a bilateral, distributed mechanism. J Neurophysiol 1999;82:1934–43.
[21]. Coghill RC, Talbot JD, Evans AC, Meyer E, Gjedde A, Bushnell MC, Duncan GH. Distributed processing of pain and vibration by the human brain. J Neurosci 1994;14:4095–108.
[22]. Creswell JD. Mindfulness interventions. Annu Rev Psychol 2017;68:491–516.
[23]. Creswell JD, Taren AA, Lindsay EK, Greco CM, Gianaros PJ, Fairgrieve A, Marsland AL, Brown KW, Way BM, Rosen RK, Ferris JL. Alterations in resting-state functional connectivity link mindfulness meditation with reduced interleukin-6: a randomized controlled trial. Biol Psychiatry 2016;80:53–61.
[24]. Creswell JD, Way BM, Eisenberger NI, Lieberman MD. Neural correlates of dispositional mindfulness during affect labeling. Psychosomatic Med 2007;69:560–5.
[25]. Crick F. Function of the thalamic reticular complex: the searchlight hypothesis. Proc Natl Acad Sci U S A 1984;81:4586–90.
[26]. Critchley HD, Wiens S, Rotshtein P, Ohman A, Dolan RJ. Neural systems supporting interoceptive awareness. Nat Neurosci 2004;7:189–95.
[27]. Daubenmier J, Hayden D, Chang V, Epel E. It's not what you think, it's how you relate to it: dispositional mindfulness moderates the relationship between psychological distress and the cortisol awakening response. Psychoneuroendocrinology 2014;48:11–18.
[28]. Davey CG, Pujol J, Harrison BJ. Mapping the self in the brain's default mode network. NeuroImage 2016;132:390–7.
[29]. Davis MC, Zautra AJ. An online mindfulness intervention targeting socioemotional regulation in fibromyalgia: results of a randomized controlled trial. Ann Behav Med 2013;46:273–84.
[30]. Day MA, Smitherman A, Ward LC, Thorn BE. An investigation of the associations between measures of mindfulness and pain catastrophizing. Clin J Pain 2015;31:222–8.
[31]. Deyo RA, Mirza SK, Turner JA, Martin BI. Overtreating chronic back pain: time to back off? J Am Board Fam Med 2009;22:62–8.
[32]. Dunne J. Toward an understanding of non-dual mindfulness. Contemp Buddhism 2011;12:69–86.
[33]. Dzau VJ, Pizzo PA. Relieving pain in America: insights from an Institute of Medicine committee. JAMA 2014;312:1507–8.
[34]. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Buchel C. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009;63:533–43.
[35]. Eippert F, Veit R, Weiskopf N, Erb M, Birbaumer N, Anders S. Regulation of emotional responses elicited by threat-related stimuli. Hum Brain Mapp 2007;28:409–23.
[36]. Farb NA, Anderson AK, Mayberg H, Bean J, McKeon D, Segal ZV. Minding one's emotions: mindfulness training alters the neural expression of sadness. Emotion 2010;10:25–33.
[37]. Fox KC, Christoff K. Transcranial direct current stimulation to lateral prefrontal cortex could increase meta-awareness of mind wandering. Proc Natl Acad Sci U S A 2015;112:E2414.
[38]. Fox SD, Flynn E, Allen RH. Mindfulness meditation for women with chronic pelvic pain: a pilot study. J Reprod Med 2011;56:158–62.
[39]. Frid M, Singer G. Hypnotic analgesia in conditions of stress is partially reversed by naloxone. Psychopharmacology (Berl) 1979;63:211–15.
[40]. Gard T, Holzel BK, Sack AT, Hempel H, Lazar SW, Vaitl D, Ott U. Pain attenuation through mindfulness is associated with decreased cognitive control and increased sensory processing in the brain. Cereb Cortex 2012;22:2692–702.
[41]. Garland EL, Gaylord SA, Palsson O, Faurot K, Douglas Mann J, Whitehead WE. Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. J Behav Med 2012;35:591–602.
[42]. Garland EL, Manusov EG, Froeliger B, Kelly A, Williams JM, Howard MO. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. J Consult Clin Psychol 2014;82:448–59.
[43]. Gatchel RJ, Licciardone JC. Mindfulness-based stress reduction vs cognitive behavioral therapy for chronic low back pain. JAMA 2016;316:663.
[44]. Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, Frey W, Leniek K, Whitehead WE. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol 2011;106:1678–88.
[45]. Grant JA, Courtemanche J, Rainville P. A non-elaborative mental stance and decoupling of executive and pain-related cortices predicts low pain sensitivity in Zen meditators. PAIN 2011;152:150–6.
[46]. Grant JA, Rainville P. Pain sensitivity and analgesic effects of mindful states in Zen meditators: a cross-sectional study. Psychosomatic Med 2009;71:106–14.
[47]. Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia by naloxone. PAIN 1983;16:129–43.
[48]. Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in well-being. Psychother Psychosom 2007;76:226–33.
[49]. Halassa MM, Chen Z, Wimmer RD, Brunetti PM, Zhao S, Zikopoulos B, Wang F, Brown EN, Wilson MA. State-dependent architecture of thalamic reticular subnetworks. Cell 2014;158:808–21.
[50]. Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. JAMA 2015;314:1468–78.
[51]. Harris RE, Zubieta JK, Scott DJ, Napadow V, Gracely RH, Clauw DJ. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). NeuroImage 2009;47:1077–85.
[52]. Harrison R, Zeidan F, Kitsaras G, Ozcelik D, Salomons TV. Trait mindfulness is associated with lower pain reactivity and connectivity of the default mode network. J Pain 2018: –.
[53]. Holzel BK, Lazar SW, Gard T, Schuman-Olivier Z, Vago DR, Ott U. How does mindfulness meditation work? Proposing mechanisms of action from a conceptual and neural perspective. Perspect Psychol Sci 2011;6:537–59.
[54]. Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 1975;258:577–80.
[55]. Jain S, Shapiro SL, Swanick S, Roesch SC, Mills PJ, Bell I, Schwartz GE. A randomized controlled trial of mindfulness meditation versus relaxation training: effects on distress, positive states of mind, rumination, and distraction. Ann Behav Med 2007;33:11–21.
[56]. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry 1982;4:33–47.
[57]. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain, and illness. New York, NY: Delacourt, 1990.
[58]. Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med 1985;8:163–90.
[59]. Kabat-Zinn J. Mindfulness-based interventions in context: past, present, and future. Clin Psychol Sci Pract 2003;10:144–56.
[60]. Kety SS, Schmidt CF. The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J Clin Invest 1948;27:484–92.
[61]. King CD, Goodin B, Kindler LL, Caudle RM, Edwards RR, Gravenstein N, Riley JL III, Fillingim RB. Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing. J Behav Med 2013;36:315–27.
[62]. Kingston J, Chadwick P, Meron D, Skinner TC. A pilot randomized control trial investigating the effect of mindfulness practice on pain tolerance, psychological well-being, and physiological activity. J Psychosom Res 2007;62:297–300.
[63]. Kong J, Gollub RL, Rosman IS, Webb JM, Vangel MG, Kirsch I, Kaptchuk TJ. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci 2006;26:381–8.
[64]. Koyama T, McHaffie JG, Laurienti PJ, Coghill RC. The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A 2005;102:12950–5.
[65]. Kucyi A, Moayedi M, Weissman-Fogel I, Goldberg MB, Freeman BV, Tenenbaum HC, Davis KD. Enhanced medial prefrontal-default mode network functional connectivity in chronic pain and its association with pain rumination. J Neurosci 2014;34:3969–75.
[66]. Lazar SW, Bush G, Gollub RL, Fricchione GL, Khalsa G, Benson H. Functional brain mapping of the relaxation response and meditation. Neuroreport 2000;11:1581–5.
[67]. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet 1978;2:654–7.
[68]. Lindsay EK, Young S, Smyth JM, Brown KW, Creswell JD. Acceptance lowers stress reactivity: dismantling mindfulness training in a randomized controlled trial. Psychoneuroendocrinology 2018;87:63–73.
[69]. Lord JA, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid peptides: multiple agonists and receptors. Nature 1977;267:495–9.
[70]. Lui F, Colloca L, Duzzi D, Anchisi D, Benedetti F, Porro CA. Neural bases of conditioned placebo analgesia. PAIN 2010;151:816–24.
[71]. Lutz A, McFarlin DR, Perlman DM, Salomons TV, Davidson RJ. Altered anterior insula activation during anticipation and experience of painful stimuli in expert meditators. NeuroImage 2013;64:538–46.
[72]. Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attention regulation and monitoring in meditation. Trends Cogn Sci 2008;12:163–9.
[73]. Lutz J, Herwig U, Opialla S, Hittmeyer A, Jancke L, Rufer M, Grosse Holtforth M, Bruhl AB. Mindfulness and emotion regulation—an fMRI study. Soc Cogn Affect Neurosci 2014;9:776–85.
[74]. MacCoon DG, Imel ZE, Rosenkranz MA, Sheftel JG, Weng HY, Sullivan JC, Bonus KA, Stoney CM, Salomons TV, Davidson RJ, Lutz A. The validation of an active control intervention for Mindfulness Based Stress Reduction (MBSR). Behav Res Ther 2012;50:3–12.
[75]. MacCoon DG, MacLean KA, Davidson RJ, Saron CD, Lutz A. No sustained attention differences in a longitudinal randomized trial comparing mindfulness based stress reduction versus active control. PLoS One 2014;9:e97551.
[76]. Maki-Marttunen V, Castro M, Olmos L, Leiguarda R, Villarreal M. Modulation of the default-mode network and the attentional network by self-referential processes in patients with disorder of consciousness. Neuropsychologia 2016;82:149–60.
[77]. Mantyh PW. Connections of midbrain periaqueductal gray in the monkey. I. Ascending efferent projections. J Neurophysiol 1983;49:567–81.
[78]. Mantyh PW. Connections of midbrain periaqueductal gray in the monkey. II. Descending efferent projections. J Neurophysiol 1983;49:582–94.
[79]. May LM, Kosek P, Zeidan F, Berkman ET. Enhancement of meditation analgesia by opioid antagonist in experienced meditators. Psychosomatic Med 2018;80:807–813.
[80]. McAlonan K, Cavanaugh J, Wurtz RH. Attentional modulation of thalamic reticular neurons. J Neurosci 2006;26:4444–50.
[81]. McCracken LM, Gauntlett-Gilbert J, Vowles KE. The role of mindfulness in a contextual cognitive-behavioral analysis of chronic pain-related suffering and disability. PAIN 2007;131:63–9.
[82]. Morone NE, Greco CM, Moore CG, Rollman BL, Lane B, Morrow LA, Glynn NW, Weiner DK. A mind-body program for older adults with chronic low back pain: a randomized clinical trial. JAMA Intern Med 2016;176:329–37.
[83]. Morone NE, Greco CM, Weiner DK. Mindfulness meditation for the treatment of chronic low back pain in older adults: a randomized controlled pilot study. PAIN 2008;134:310–19.
[84]. Nelson LS, Juurlink DN, Perrone J. Addressing the opioid epidemic. JAMA 2015;314:1453–4.
[85]. O'Doherty J, Kringelbach ML, Rolls ET, Hornak J, Andrews C. Abstract reward and punishment representations in the human orbitofrontal cortex. Nat Neurosci 2001;4:95–102.
[86]. Oshiro Y, Quevedo AS, McHaffie JG, Kraft RA, Coghill RC. Brain mechanisms supporting discrimination of sensory features of pain: a new model. J Neurosci 2009;29:14924–31.
[87]. Perthen JE, Bydder M, Restom K, Liu TT. SNR and functional sensitivity of BOLD and perfusion-based fMRI using arterial spin labeling with spiral SENSE at 3 T. Magn Reson Imaging 2008;26:513–22.
[88]. Peters J, Buchel C. Neural representations of subjective reward value. Behav Brain Res 2010;213:135–41.
[89]. Petrovic P, Kalso E, Petersson KM, Andersson J, Fransson P, Ingvar M. A prefrontal non-opioid mechanism in placebo analgesia. PAIN 2010;150:59–165.
[90]. Petter M, Chambers CT, McGrath PJ, Dick BD. The role of trait mindfulness in the pain experience of adolescents. J Pain 2013;14:1709–18.
[91]. Poerio GL, Sormaz M, Wang HT, Margulies D, Jefferies E, Smallwood J. The role of the default mode network in component processes underlying the wandering mind. Soc Cogn Affect Neurosci 2017;12:1047–62.
[92]. Rahl HA, Lindsay EK, Pacilio LE, Brown KW, Creswell JD. Brief mindfulness meditation training reduces mind wandering: the critical role of acceptance. Emotion 2017;17:224–30.
[93]. Restom K, Behzadi Y, Liu TT. Physiological noise reduction for arterial spin labeling functional MRI. NeuroImage 2006;31:1104–15.
[94]. Rolls ET, Grabenhorst F. The orbitofrontal cortex and beyond: from affect to decision-making. Prog Neurobiol 2008;86:216–44.
[95]. Rosenkranz MA, Davidson RJ, Maccoon DG, Sheridan JF, Kalin NH, Lutz A. A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation. Brain Behav Immun 2013;27:174–84.
[96]. Rostrup E, Law I, Blinkenberg M, Larsson HB, Born AP, Holm S, Paulson OB. Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study. NeuroImage 2000;11:87–97.
[97]. Salomons TV, Johnstone T, Backonja MM, Shackman AJ, Davidson RJ. Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex. J Cogn Neurosci 2007;19:993–1003.
[98]. Saloner B, Karthikeyan S. Changes in substance abuse treatment use among individuals with opioid use disorders in the United States, 2004–2013. JAMA 2015;314:1515–17.
[99]. Schooler JW, Smallwood J, Christoff K, Handy TC, Reichle ED, Sayette MA. Meta-awareness, perceptual decoupling and the wandering mind. Trends Cogn Sci 2011;15:319–26.
[100]. Schutze R, Rees C, Preece M, Schutze M. Low mindfulness predicts pain catastrophizing in a fear-avoidance model of chronic pain. PAIN 2010;148:120–7.
[101]. Seminowicz DA, Mikulis DJ, Davis KD. Cognitive modulation of pain-related brain responses depends on behavioral strategy. PAIN 2004;112:48–58.
[102]. Seminowicz DA, Moayedi M. The dorsolateral prefrontal cortex in acute and chronic pain. J Pain 2017;18:1027–35.
[103]. Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol 2006;62:373–86.
[104]. Sharon H, Ben Simon E, Tarrasch R. The reply. Am J Med 2016;129:e299.
[105]. Sharon H, Maron-Katz A, Ben Simon E, Flusser Y, Hendler T, Tarrasch R, Brill S. Mindfulness meditation modulates pain through endogenous opioids. Am J Med 2016;129:755–8.
[106]. Shires A, Sharpe L, Newton John TRO. The relative efficacy of mindfulness versus distraction: the moderating role of attentional bias. Eur J Pain 2018;4:727–38.
[107]. Spreng RN, Grady CL. Patterns of brain activity supporting autobiographical memory, prospection, and theory of mind, and their relationship to the default mode network. J Cogn Neurosci 2010;22:1112–23.
[108]. Sprenger C, Eippert F, Finsterbusch J, Bingel U, Rose M, Buchel C. Attention modulates spinal cord responses to pain. Curr Biol 2012;22:1019–22.
[109]. Starr CJ, Sawaki L, Wittenberg GF, Burdette JH, Oshiro Y, Quevedo AS, Coghill RC. Roles of the insular cortex in the modulation of pain: insights from brain lesions. J Neurosci 2009;29:2684–94.
[110]. Stephenson JB. Reversal of hypnosis-induced analgesia by naloxone. Lancet 1978;2:991–2.
[111]. Steward T, Pico-Perez M, Mata F, Martinez-Zalacain I, Cano M, Contreras-Rodriguez O, Fernandez-Aranda F, Yucel M, Soriano-Mas C, Verdejo-Garcia A. Emotion regulation and excess weight: impaired affective processing characterized by dysfunctional insula activation and connectivity. PLoS One 2016;11:e0152150.
[112]. Svedin BT, Payne A, Parker DL. Respiration artifact correction in three-dimensional proton resonance frequency MR thermometry using phase navigators. Magn Reson Med 2016;76:206–13.
[113]. Tang YY, Holzel BK, Posner MI. The neuroscience of mindfulness meditation. Nat Rev Neurosci 2015;16:213–25.
[114]. Taylor VA, Grant J, Daneault V, Scavone G, Breton E, Roffe-Vidal S, Courtemanche J, Lavarenne AS, Beauregard M. Impact of mindfulness on the neural responses to emotional pictures in experienced and beginner meditators. NeuroImage 2011;57:1524–33.
[115]. Taylor VA, Roy M, Chang L, Gill LN, Mueller C, Rainville P. Reduced fear-conditioned pain modulation in experienced meditators: a preliminary study. Psychosomatic Med 2018;80:799–806.
[116]. Teper R, Inzlicht M. Meditation, mindfulness and executive control: the importance of emotional acceptance and brain-based performance monitoring. Soc Cogn Affect Neurosci 2013;8:85–92.
[117]. Tracey I, Ploghaus A, Gati JS, Clare S, Smith S, Menon RS, Matthews PM. Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 2002;22:2748–52.
[118]. Turner JA, Anderson ML, Balderson BH, Cook AJ, Sherman KJ, Cherkin DC. Mindfulness-based stress reduction and cognitive behavioral therapy for chronic low back pain: similar effects on mindfulness, catastrophizing, self-efficacy, and acceptance in a randomized controlled trial. PAIN 2016;157:2434–44.
[119]. Vago DR, Nakamura Y. Selective attentional bias towards pain-related threat in fibromyalgia: preliminary evidence for effects of mindfulness meditation training. Cogn Ther Res 2011;35:581–94.
[120]. Valet M, Sprenger T, Boecker H, Willoch F, Rummeny E, Conrad B, Erhard P, Tolle TR. Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain—an fMRI analysis. PAIN 2004;109:399–408.
[121]. Villemure C, Bushnell MC. Mood influences supraspinal pain processing separately from attention. J Neurosci 2009;29:705–15.
[122]. Wager TD, Atlas LY, Leotti LA, Rilling JK. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J Neurosci 2011;31:439–52.
[123]. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, Kosslyn SM, Rose RM, Cohen JD. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science 2004;303:1162–7.
[124]. Wager TD, Scott DJ, Zubieta JK. Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A 2007;104:11056–61.
[125]. Wallace BA. The attention revolution: Unlocking the power of the focused mind. Somerville: Wisdom Publications, 2006.
[126]. Wang J, Aguirre GK, Kimberg DY, Roc AC, Li L, Detre JA. Arterial spin labeling perfusion fMRI with very low task frequency. Magn Reson Med 2003;49:796–802.
[127]. Watkins LR, Mayer DJ. Organization of endogenous opiate and nonopiate pain control systems. Science 1982;216:1185–92.
[128]. Way BM, Creswell JD, Eisenberger NI, Lieberman MD. Dispositional mindfulness and depressive symptomatology: correlations with limbic and self-referential neural activity during rest. Emotion 2010;10:12–24.
[129]. Weese GD, Phillips JM, Brown VJ. Attentional orienting is impaired by unilateral lesions of the thalamic reticular nucleus in the rat. J Neurosci 1999;19:10135–9.
[130]. Wells RE, Burch R, Paulsen RH, Wayne PM, Houle TT, Loder E. Meditation for migraines: a pilot randomized controlled trial. Headache 2014;54:1484–95.
[131]. Xu F, Uh J, Brier MR, Hart J Jr, Yezhuvath US, Gu H, Yang Y, Lu H. The influence of carbon dioxide on brain activity and metabolism in conscious humans. J Cereb Blood Flow Metab 2011;31:58–67.
[132]. Zeidan F The neurobiology of mindfulness meditation. In: KW Brown, Creswell JD, RM Ryan, editors. Handbook of mindfulness science: Theory, research and practice. New York: The Guilford Press, 2015.
[133]. Zeidan F. No, mindfulness meditation-based analgesia is not mediated by endogenous opioids. Am J Med 2016;129:e297.
[134]. Zeidan F, Adler-Neal AL, Wells RE, Stagnaro E, May LM, Eisenach JC, McHaffie JG, Coghill RC. Mindfulness-meditation-based pain relief is not mediated by endogenous opioids. J Neurosci 2016;36:3391–7.
[135]. Zeidan F, Emerson NM, Farris SR, Ray JN, Jung Y, McHaffie JG, Coghill RC. Mindfulness meditation-based pain relief employs different neural mechanisms than placebo and sham mindfulness meditation-induced analgesia. J Neurosci 2015;35:15307–25.
[136]. Zeidan F, Gordon NS, Merchant J, Goolkasian P. The effects of brief mindfulness meditation training on experimentally induced pain. J Pain 2010;11:199–209.
[137]. Zeidan F, Grant JA, Brown CA, McHaffie JG, Coghill RC. Mindfulness meditation-related pain relief: evidence for unique brain mechanisms in the regulation of pain. Neurosci Lett 2012;520:165–73.
[138]. Zeidan F, Johnson SK, Diamond BJ, David Z, Goolkasian P. Mindfulness meditation improves cognition: evidence of brief mental training. Conscious Cogn 2010;19:597–605.
[139]. Zeidan F, Johnson SK, Gordon NS, Goolkasian P. Effects of brief and sham mindfulness meditation on mood and cardiovascular variables. J Altern Complement Med 2010;16:867–73.
[140]. Zeidan F, Lobanov OV, Kraft RA, Coghill RC. Brain mechanisms supporting violated expectations of pain. PAIN 2015;154:1772–85.
[141]. Zeidan F, Martucci KT, Kraft RA, Gordon NS, McHaffie JG, Coghill RC. Brain mechanisms supporting the modulation of pain by mindfulness meditation. J Neurosci 2011;31:5540–8.
[142]. Zeidan F, Salomons T, Farris SR, Emerson NM, Adler-Neal A, Jung Y, Coghill RC. Neural mechanisms supporting the relationship between dispositional mindfulness and pain. PAIN 2018;159:2477–85.
[143]. Zeidan F, Vago DR. Mindfulness meditation-based pain relief: a mechanistic account. Ann N Y Acad Sci 2016;1373:114–27.
[144]. Zikopoulos B, Barbas H. Circuits formultisensory integration and attentional modulation through the prefrontal cortex and the thalamic reticular nucleus in primates. Rev Neurosci 2007;18:417–38.
[145]. Zikopoulos B, Barbas H. Parallel driving and modulatory pathways link the prefrontal cortex and thalamus. PLoS One 2007;2:e848.
[146]. Zikopoulos B, Barbas H. Pathways for emotions and attention converge on the thalamic reticular nucleus in primates. J Neurosci 2012;32:5338–50.
[147]. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, Nichols TE, Stohler CS. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci 2005;25:7754–62.
Keywords:

Mindfulness; Pain; fMRI; Placebo; Meditation

© 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain.